Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma

High Grade Sarcoma Clinical Trial

Official title:
Phase 2 Clinical Trial of Radiomic Habitat-Directed Radiation Dose Escalation for High-Grade Soft Tissue Sarcoma

Status Recruiting

Clinical Trial Summary

The purpose of the study is to utilize radiomic images to precisely locate areas of tumor that can be treated with dose escalation radiation therapy.

n/a

NCT number	NCT05301283
Study type	Interventional
Source	H. Lee Moffitt Cancer Center and Research Institute
Contact	Lauren (Taylor) Michael
Phone	813-745-3104
Email	Lauren.Michael@moffitt.org
Status	Recruiting
Phase	Phase 2
Start date	May 18, 2022
Completion date	March 31, 2025

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05515068` - Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Withdrawn	`NCT04906876` - A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas	Phase 2
Terminated	`NCT01010958` - Adjuvant Valproate for High Grade Sarcomas	Phase 1
Terminated	`NCT02601209` - Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma	Phase 1/Phase 2
Not yet recruiting	`NCT03951571` - Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma	Phase 2
Withdrawn	`NCT05116800` - Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma	Phase 2
Active, not recruiting	`NCT04242238` - Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas	Phase 1